A. Research Papers

1. Young, J.M., Hiley, R. & Burgen, A.S.V. (1972). Homologues of benzilylcholine mustard. J. Pharm. Pharmacol. 24: 950-954
2. Cuello, A.C., Hiley, R. & Iversen, L.L. (1973). Use of catechol-O-methyltransferase for the enzyme radiochemical assay of dopamine. J. Neurochem. 21: 1337-1340
3. Burgen, A.S.V., Hiley, C.R. & Young, J.M. (1974). The binding of [3H] propyl-benzilylcholine mustard by longitudinal muscle strips from guinea-pig small intestine. Br. J. Pharmacol. 50: 145-151
4. Burgen, A.S.V., Hiley, C.R. & Young, J.M. (1974). The properties of muscarinic receptors in mammalian cerebral cortex. Br. J. Pharmacol. 51: 279-285
5. Hiley, C.R. & Burgen, A.S.V. (1974). The distribution of muscarinic receptor in the nervous system of the dog. J. Neurochem. 22: 159-162
6. Hiley, C.R. & Bird, E.D. (1974). Decreased muscarinic receptor concentration in post-mortem brain in Huntington's chorea. Brain Res. 80: 355-358
7. Miller, R.J. & Hiley, C.R. (1974). Antimuscarinic properties of neuroleptics and drug-induced Parkinsonism. Nature 248: 596-597
8. Birdsall, N.J.M., Burgen, A.S.V., Hiley, C.R. & Hulme, E.C. (1976). Binding of agonists and antagonists to muscarinic receptors. J. Supramol. Structure 4: 367-372
9. Miller, R.J. & Hiley, C.R. (1976). Anti-dopaminergic and anti-muscarinic effects of dibenzodiazepines: Relationship to drug induced Parkinsonism. Naunyn Schmiedebergs Arch. Pharmacol. 292: 289-293
10. White, P., Hiley, C.R., Goodhardt, M.J., Carrasco, L.H., Keet, J.P., Williams, I.E.I. & Bowen, D.M. (1977). Neocortical cholinergic neurones in elderly people. Lancet 1: 668-670
11. Hiley, C.R., Wilson, H. & Yates, M.S. (1978). Identification of beta-adrenoceptors and histamine receptors in the cat nasal vasculature. Acta Oto-Laryngolica 85: 444-448
12. Hiley, C.R. & Yates, M.S. (1978). The distribution of cardiac output in the anaesthetised spontaneously hypertensive rat. Clin. Sci. Mol. Med. 55: 317-320
13. Hiley, C.R., Yates, M.S. & Back, D.J. (1978). The effect of urethane and pentobarbital anaesthesia and hepatic portal vein catheterization on liver blood flow in the rat. Experientia 34: 1061-1062
14. Yates, M.S., Hiley, C.R., Roberts, P.J., Back, D.J. & Crawford, F.E. (1978). Differential effects of hepatic microsomal enzyme inducing agents on liver blood flow. Biochem. Pharmacol. 27: 2617-2621
15. Yates, M.S. & Hiley, C.R. (1979). The effect of age on cardiac output and its distribution in the rat. Experientia 35: 78-79
16. Yates, M.S., Hiley, C.R. & Back, D.J. (1979). Effects of phenobarbitone on hepatic microsomal enzyme activity and liver blood flow in spontaneously hypertensive rats. Life Sciences 24: 535-540
17. Back, D.J., Cross, K.J., Hiley, C.R. & Yates, M.S. (1979). The effect of rifampicin on liver blood flow, microsomal enzyme activity and bile flow in the rat. Biochem. Pharmacol. 28: 1293-1296
18. Yates, M.S. & Hiley, C.R. (1979). Distribution of cardiac output in different models of hypertension in the conscious rat. Pflugers Archiv. 379: 219-222
19. Yates, M.S. & Hiley, C.R. (1979). Haemodynamic effects of systemic administration of clonidine in the anaesthetized spontaneously hypertensive rat. J. Pharm. Pharmacol. 31: 483-485
20. Yates, M.S., Hiley, C.R., Challiner, M.R. & Park, B.K. (1979). Phenobarbitone effects on hepatic microsomal enzymes and liver blood flow in the guinea-pig. Biochem. Pharmacol. 28: 2856-2857
21. Hiley, C.R., Yates, M.S., Roberts, P.J. & Bloom, A.E. (1980). Alterations in liver blood flow during glycerol-induced acute renal failure in the rat. Nephron. 26: 244-248
22. Hill, S.J., Hiley, C.R. & Young, J.M. (1981). Extended mepyramine treatment and histamine H1-receptors in guinea-pig brain. Eur. J. Pharmacol. 71: 421-428
23. Berman, J.S., Hiley, C.R. & Wilson, A.C. (1983). Comparison of the effects of the hypolipidaemic agents ICI 53072 and clofibrate with those of phenobarbitone on liver size, blood flow and DNA content in the rat. Br. J. Pharmacol. 78: 533-541
24. Wilson, A.C. & Hiley, C.R. (1983). Effects of some hepatomegalic agents on liver DNA content: relationship to changes in liver blood flow. J. Pharm. Pharmacol. 35: 191-194
25. Malcolm, R.E. & Hiley, C.R. (1984). Short term reductions in cerebral muscarinic receptor concentration of the mouse after in vivo administration of cycloheximide. Biochem. Pharmacol. 33: 1605-1610
26. Nichols, A.J., Wilson, A.C. & Hiley, C.R. (1985). Effects of chemical sympathectomy with 6-hydroxydopamine on cardiac output and its distribution in the rat. Eur. J. Pharmacol. 109: 263-268
27. Nichols, A.J. & Hiley, C.R. (1985). Identification of adrenoceptors and dopamine receptors mediating vascular responses in the superior mesenteric arterial bed of the rat. J. Pharm. Pharmacol. 37: 110-115
28. Hiley, C.R., Nichols, A.J. & Wilson, A.C. (1985). Effects of phenobarbitone and 6 methylprednisolone pretreatment on pressure/flow relationships in the superior mesenteric and iliac arterial beds of the rat. J. Pharm. Pharmacol. 37: 164-169
29. Nichols, A.J. & Hiley, C.R. (1985). Lack of effect of several barbiturates on liver blood flow. Biochem. Pharmacol. 34: 3776-3778
30. Hiley, C.R., Nichols, A.J. & Thomas, G.R. (1986). Interactions between noradrenaline and alpha2-adrenoceptor agonists in the superior mesenteric arterial bed of the rat. Br. J. Pharmacol. 89: 779-785
31. Hiley, C.R. & Thomas, G.R. (1987). Effects of alpha-adrenoceptor agonists on cardiac output and its regional distribution in the rat. Br. J. Pharmacol. 90: 61-70
32. Nichols, A.J. & Hiley, C.R. (1987). Comparison of the effects of intravenous and intrasplenic infusions of glucagon on cardiac output and its distribution in the rat. Naunyn-Schmiedeberg's Arch. Pharmacol. 335: 344-350
33. MacLean, M.R. & Hiley, C.R. (1988). Effects of enalapril on changes in cardiac output and organ vascular resistances induced by alpha1- and alpha2 - adrenoceptor agonists in pithed normotensive rats. Br. J. Pharmacol. 94: 449-462
34. Randall, M.D. & Hiley, C.R. (1988). Effect of phenobarbitone pretreatment upon endothelium-dependent relaxation to acetylcholine in rat superior mesenteric arterial bed. Br. J. Pharmacol. 94: 977-983
35. MacLean, M.R. & Hiley, C.R. (1988). Effect of artificial respiratory volume on the cardiovascular responses to an alpha1- and an alpha2-adrenoceptor agonist in the air-respired pithed rat. Br. J. Pharmacol. 93: 781-790
36. Randall, M.D., Kay, A. & Hiley, C.R. (1988). Endothelium-dependent modulation of the pressor activity of arginine vasopressin in the isolated superior mesenteric arterial bed of the rat. Br. J. Pharmacol. 95: 646-652
37. Thomas, G.R. & Hiley, C.R. (1988). Cardiovascular effects of intracerebroventricular bradykinin and melittin in the rat. J. Pharm. Pharmacol. 40:721-723
38. Randall, M.D. & Hiley, C.R. (1988). Detergent and methylene blue affect endothelium-dependent vasorelaxation and pressure/flow relations in rat blood perfused superior mesenteric arterial bed. Br. J. Pharmacol. 95: 1081-1088
39. Jones, C.R., Hiley, C.R., Pelton, J. T. & Mohr, M. (1989). Autoradiographic visualization of the binding sites for [I-125]endothelin in rat and human brain. Neurosci. Lett. 97: 276-279
40. Jones, C.R., Hiley, C.R., Pelton, J.T. & Miller, R.C. (1989). Autoradiographic localisation of endothelin binding sites in kidney. Eur. J. Pharmacol. 163: 379-382
41. MacLean, M.R., Thomson, M. & Hiley, C.R. (1989). Pressor effects of the alpha2-adrenoceptor agonist B HT 933 in anaesthetised and haemorrhagic rats: comparison with the haemodynamic effects of amidephrine. Br. J. Pharmacol. 97:419-432
42. Randall, M.D., Douglas, S.A. & Hiley, C.R. (1989). Vascular activities of endothelin 1 and some alanyl substituted analogues in resistance beds of the rat. Br. J. Pharmacol. 98: 685-689
43. MacLean, M.R., Randall M.D. & Hiley, C.R. (1989). Effects of moderate hypoxia, hypercapnia and acidosis on haemodynamic changes induced by endothelin-1 in the pithed rat. Br. J. Pharmacol. 98: 1055-1065
44. Crawford, M.L.A., Hiley, C.R. & Young, J.M. (1990). Characteristics of endothelin-1 and endothelin-3 stimulation of phosphoinositide breakdown differ between regions of guinea-pig and rat brain. Naunyn Schmiedeberg's Arch. Pharmacol. 341: 268-271
45. MacLean, M.R. & Hiley, C.R. (1990). Effects of neuropeptide Y on cardiac output, its distribution, regional blood flow and organ vascular resistance in the pithed rat. Br. J. Pharmacol. 99: 340-342
46. Douglas, S.A. & Hiley, C.R. (1990). Endothelium-dependent vascular activities of some endothelin like peptides in the isolated superior mesenteric arterial bed of the rat. Br. J. Pharmacol. 101: 81-88
47. Hiley, C.R., Jones, C.R., Pelton, J.T. & Miller, R.C. (1990). Binding of [I-125]endothelin-1 to rat cerebellar homogenates and its interactions with some analogues. Br. J. Pharmacol. 101: 319-324
48. Jones, C.R., Hiley, C.R., Pelton, J.T. & Miller, R.C. (1991). Endothelin receptor heterogeneity; structure activity, autoradiographic and functional studies. J. Receptor. Res. 11: 299-310
49. Douglas, S.A. & Hiley, C.R. (1991). Responses to endothelin-1, human proendothelin (1-38) and porcine proendothelin (1-39) in the rat on intravenous administration and in the blood perfused mesentery. Neurochem. Int. 18: 445-454
50. Randall, M.D., Thomas, G.R. & Hiley, C.R. (1991). Effect of destruction of the vascular endothelium upon pressure/flow relations and endothelium-dependent vasodilatation in resistance beds of spontaneously hypertensive rats. Clin. Sci. 80: 463-469
51. Douglas, S.A., James, S. & Hiley, C.R. (1991). Endothelial modulation and changes in endothelin pressor activity during hypoxia in the rat isolated perfused superior mesenteric arterial bed. Br. J. Pharmacol. 103: 1441-1448
52. Keravis, T.M., Nehlig, H., Delacroix, M.-F., Regoli, D., Hiley, C.R. & Stoclet, J.-C. (1991). High affinity B2 bradykinin binding sites sensitive to guanine nucleotides in bovine aortic endothelial cells. Eur. J. Pharmacol. 207: 149-155.
53. Douglas, S.A. & Hiley, C.R. (1991). Endothelium-dependent mesenteric vasorelaxant effects and systemic actions of endothelin (16-21) and other endothelin-related peptides in the rat. Br. J. Pharmacol. 104: 311-320
54. Hiley, C.R., Cowley, D.J., Pelton, J.T. & Hargreaves, A.C. (1992). BQ 123, CYCLO(-D-Trp-D-Asp-Pro-D-Val-Leu), is a non-competitive antagonist of the actions of endothelin-1 in SK-N-MC human neuroblastoma cells. Biochem. Biophys. Res. Commun. 184: 504-510.
55. Privitera, P.J., Daum, P.R., Hill, D.R. & Hiley, C.R. (1992). Autoradiographic visualization and characteristics of [I-125]bradykinin binding sites in guinea pig brain. Brain Res. 577: 73-79.
56. Wren, A.D., Hiley , C.R. & Fan, T.-P.D. (1993). Endothelin-3 mediated proliferation in wounded human umbilical vein endothelial cells. Biochem. Biophys. Res. Commun. 196: 369-375
57. Hu, D.-E., Hiley, C.R., Smither, R.L., Gresham, G.A. & Fan, T.-P.D. (1995). Correlation of 133Xe clearance, blood flow and histology in the rat sponge model for angiogenesis: further studies with angiogenic modifiers. Lab. Invest. 72: 601-610
58. Hiley, C.R., Bottrill, F.E., Warnock, J. & Richardson, P.J. (1995). Effects of pH on responses to adenosine, CGS 21680, carbachol and nitroprusside in the isolated perfused superior mesenteric arterial bed of the rat. Br. J. Pharmacol. 116: 2641-2646
59. Hu, D.-E., Hiley, C.R. & Fan, T.-P.D. (1996). Comparative studies of the angiogenic activity of vasoactive intestinal peptide, endothelins 1 and 3 and angiotensin II in a rat sponge model. Br. J. Pharmacol. 117: 545-551
60. McCulloch, A.I., Bottrill, F.E., Randall, M.D. & Hiley, C.R. (1997). Characterization and modulation of EDHF-mediated relaxations in the rat isolated superior mesenteric arterial bed. Br. J. Pharmacol. 120: 1431-1438
61. White, R. & Hiley, C.R. (1997). A comparison of EDHF-mediated and anandamide-induced relaxations in the rat isolated mesenteric artery. Br. J. Pharmacol. 122: 1573-1584
62. White, R. & Hiley, C.R. (1997). Endothelium and cannabinoid receptor involvement in levcromakalim vasorelaxation. Eur. J. Pharmacol. 339: 157-160
63. Lauder, H., Frost, E.E., Hiley, C.R. & Fan, T.-P.D. (1998). Quantification of the repair process involved in the repair of a cell monolayer using an in vitro model of mechanical injury. Angiogenesis 2: 67-80
64. Smith, E.L.K., Lauder, H., Fan, T.-P.D., Hiley, C.R. & Hainsworth, A.H. (1998). Vascular endothelial growth factor (VEGF) and endothelin-3 (ET-3) activate cation currents in human umbilical vein endothelial cells. J. Clin. Basic Cardiol. 1: 52-54
65. White, R. & Hiley, C.R. (1998). Effects of K+ channel openers on relaxations to nitric oxide and endothelium-derived hyperpolarizing factor in rat mesenteric artery. Eur. J. Pharmacol. 357: 41-51
66. White, R. & Hiley, C.R. (1998). The actions of some cannabinoid receptor ligands in the rat isolated mesenteric artery. Br. J. Pharmacol. 125: 533-541
67. White, R. & Hiley, C.R. (1998). Modulation of relaxation to levcromakalim by S nitroso-N-acetylpenicillamine (SNAP) and 8-bromo cyclic GMP in the rat isolated mesenteric artery. Br. J. Pharmacol. 124: 1219-1226
68. White, R. & Hiley, C.R. (1998). The actions of the cannabinoid receptor antagonist, SR 141716A, in the rat isolated mesenteric artery. Br. J. Pharmacol. 125: 689-696
69. White, R. & Hiley, C.R. (2000). Hyperpolarisation of rat mesenteric endothelial cells by ATP-sensitive K+ channel openers. Eur. J. Pharmacol. 397. 279-290
70. Bottrill, F.E., Douglas, S.A., Hiley, C.R. & White, R. (2000). Human urotensin-II is an endothelium-dependent vasodilator in rat small arteries. Br. J. Pharmacol. 130: 1865-1870
71. Omar, R., Bottrill, F.E., Hiley, C.R. & White, R. (2000). Interaction of cyclic AMP modulating agents with levcromakalim in the relaxation of rat isolated mesenteric artery. Eur. J. Pharmacol. 401: 85-96
72. Vuylsteke, A., Davidson, H.J., Ho, W.-S.V., Ritchie, A.J., Callingham, B.A., White, R. & Hiley, C.R. (2001). Effect of the blood substitute diaspirin cross-linked haemoglobin (DCLHb) in rat mesenteric and human radial collateral arteries. J. Cardiovasc Pharmacol. 37: 394-405
73. White, R., Bottrill, F.E., Siau, D. & Hiley, C.R. (2001). Protein kinase A-dependent and -independent effects of isoproterenol in rat isolated mesenteric artery: interactions with levcromakalim. J. Pharmacol. Exp. Ther. 298: 917-924
74. Ford, W.R., Clanachan, A.S., Hiley, C.R. & Jugdutt, B.I. (2001). Angiotensin II reduces infarct size and has no effect on post-ischaemic contractile dysfunction in isolated rat hearts. Br. J. Pharmacol. 134: 38-45
75. White, R., Ho, W-S.V., Bottrill, F.E., Ford, W.R. & Hiley, C.R. (2001). Mechanisms of anandamide-induced vasorelaxation in rat isolated coronary arteries. Br. J. Pharmacol. 134: 921-929
76. Ford, W.R., Honan, S.A., White, R. & Hiley, C.R. (2002). Evidence of a novel site mediating anandamide-induced negative inotropic and coronary vasodilatator responses in rat isolated hearts. Br. J. Pharmacol. 135: 1191-1198
77. Ho, W-S.V. & Hiley, C.R. (2003). Vasodilator actions of abnormal-cannabidiol in rat isolated small mesenteric artery. Br. J. Pharmacol. 138: 1320-1332
78. Ho, W-S.V. & Hiley, C.R. (2003). Endothelium-independent relaxation to cannabinoids in rat isolated mesenteric artery and the role of Ca2+ influx. Br. J. Pharmacol. 139: 585-597
79. Mistry, H., Gitlin, J.M., Mitchell, J.A. & Hiley, C.R. (2003). Endothelium-dependent relaxation and endothelial hyperpolarization by P2Y agonists in rat isolated mesenteric artery. Br. J. Pharmacol. 139: 661-671
80. Benamou, A.E., Marlin, D.J., Callingham, B.C., Hiley, R.C. & Lekeux, R. (2003). Spasmogenic action of endothelin-1 on isolated equine pulmonary artery and bronchus. Equine Vet. J. 35, 190-196
81. Ho, W-S.V. & Hiley, C.R. (2004). Vasorelaxant activities of the putative endocannabinoid virodhamine in rat isolated small mesenteric artery. J. Pharm. Pharmacol. 56: 869-875
82. Visintin, C., Aliev, A.E., Riddall, D., Baker, D., Okuyama, M., Hoi, P.M., Hiley R. & Selwood, D.L. (2005). Membrane receptor probes: Solid-phase synthesis of biotin-Asp-PEG-arvanil derivatives. Org. Lett. 7: 1699-1702
83. Underdown, N.J., Hiley, C.R. & Ford, W.R. (2005). Anandamide reduces infarct size in rat isolated hearts subjected to ischaemia-reperfusion by a novel cannabinoid mechanism. Br. J. Pharmacol. 146: 809-816
84. Baker, D., Pryce, G., Davies, W.L. & Hiley, C.R. (2006). In silico patent searching reveals a new cannabinoid receptor. Trends. Pharmacol. Sci. 27:1-4
85. Hoi, P.M. & Hiley, C.R. (2006). Vasorelaxant effects of oleamide in rat small mesenteric artery indicate action at a novel cannabinoid receptor. Br. J. Pharmacol. 147: 560-568
86. Hoi, P.M., Visintin, C., Okuyama, M., Gardiner, S.M., Kaup, S.S., Bennett, T., Baker, D., Selwood, D.L. & Hiley, C.R. (2007). Vascular pharmacology of a novel cannabinoid-like compound, 3 (5 dimethylcarbamoyl-pent-1-enyl)-N-(2-hydroxy-1-methyl-ethyl)benzamide (VSN16) in the rat. Br. J. Pharmacol. 125: 751-764
87. Prime, T.A., Blaiki, F.H., Evans, C., Nadtochiy, S.M., James, A.M., Dahma, C.C., Vitturi, D.A., Rakesh P. Patel, R.P., Hiley, C.R., Abakumova, I., Requejo, R., Chouchani, E.T., Hurd, T.R., Garvey, J.F., Taylor, C.T., Brookes, P.S., Smith, R.A.J. & Murphy, M.P. (2009). A mitochondria-targeted S-nitrosothiol modulates respiration, nitrosates thiols and protects against ischemia-reperfusion injury. Proc. Natl. Acad. Sci. (USA), 106: 10764-10769

B. Scientific Reviews, Book Chapters etc.

88. Burgen, A.S.V. & Hiley, C.R. (1975). The use of an alkylating antagonist in investigating the properties of muscarinic receptors: in "Cholinergic Mechanisms" edited by P.G. Waser (Raven Press: New York) pp 381-385
89. Miller, R. & Hiley, R. (1975). Antimuscarinic actions of neuroleptic drugs: in "Advances in Neurology", Vol. 9 edited by D.B. Calne, T.N. Chase and A. Barbeau (Raven Press: New York) pp 141-154
90. Hiley, C.R. (1976). The muscarinic receptor for acetylcholine in Huntington's chorea: in "Biochemistry and Neurology", edited by H.F. Bradford and C.D. Marsden (Academic Press: London) pp 103-109
91. Hiley, C.R. (1978). Radioligands, adenylate cyclases and adrenoceptors: in "Recent Advances in the Pharmacology of Adrenoceptors" edited by E. Szabadi, C.M. Bradshaw and P. Bevan. (Elsevier/North Holland: Amsterdam) pp 99-102
92. Hiley, C.R. (1989). Functional studies on endothelin catch up with molecular biology. Trends Pharmacol. Sci. 10: 47-49
93. Hiley, C.R., Douglas, S.A. & Randall, M.D. (1989). Pressor effects of endothelin and some analogs in the perfused superior mesenteric arterial bed of the rat. J. Cardiovasc. Pharmacol. 13 (Suppl. 5): S197-S199
94. Miller, R.C., Topouzis, S., Pelton, J.T. & Hiley, C.R. (1990). Effects of endothelin and some endothelin analogues on isolated smooth muscle preparations: in "Endothelium-derived Vasoactive Factors" edited by G.M. Rubanyi and P.M. Vanhoutte. (Karger: Basel). pp 88-97
95. Hiley, C.R. (1990). Meeting reports: Chemistry and biology of endothelin. Strasbourg, France. June 1990. Trends Pharmacol. Sci. 11: 341-342
96. Fan, T.-P.D., Hu, D.-E. & Hiley, C.R. (1992). Development and validation of a sponge model for quantitative studies on angiogenesis: in "Angiogenesis in Health and Disease" edited by Maragoudis, M.E. et al. (Plenum Press: New York). pp. 317-332
97. Miller, R.C., Pelton, J.T. & Hiley, C.R. (1993). Analogs of endothelin: in "Methods in Neurosciences, Volume 13, Neuropeptide Analogs, Conjugates, and Fragments" edited by P.M. Conn. (Academic Press: San Diego, CA). pp. 139-163
98. Hiley, C.R. (1995). Endothelin receptor ligands. Neurotransmissions 11(2): 1-6
99. Miller, R.C., Galvan, M. & Hiley, C.R. (1996). Chapter 4: Receptors, ion channels and ion pumps: in "The Neurophysiological Basis of Cerebral Blood Flow Control" edited by S. Mraovitch and R. Sercombe. (John Libbey: London). pp. 87-109
100. Hu, D.E., Lauder, H., Hiley, C.R. & Fan, T.-P.D. (1997). Are angiotensin II and endothelins angiogenic? Proc. 7th South East Asia/Western Pacific Regional Meeting of Pharmacologists. pp. 169-179
101. Hiley, C.R. (1997). Chapter 1: Endothelin receptors: pharmacological subtyping, agonists, and antagonists: in "Endothelins in Biology and Medicine" edited by R. Miller, J.T. Pelton and J. Huggins. (CRC Press: Boca Raton, FL). pp. 3-26
102. Hiley, C.R. (1997). The pharmacology of vasodilators. Proc. Assn Vet. Clin. Pharmacol. Therap. 15: 31-35
103. Hiley, C.R. (2001). Nitric oxide: in "Oxford Companion to the Body" edited by C. Blakemore and S. Jennett (Oxford University Press: Oxford). pp. 483-484
104. Hiley, C.R. & Ford, W.R. (2003). Commentary: Endocannabinoids as mediators in the heart: a potential target for therapy of remodelling after myocardial infarction? Br. J. Pharmacol. 138: 1183-1184
105. Hiley, C.R. & Ford, W.R. (2004). Cannabinoid pharmacology in the cardiovascular system: potential protective mechanisms through lipid signalling. Biol. Rev.79: 187-205
106. Hiley, C.R. & Hoi, P.M. (2007). Oleamide: a fatty acid amide signaling molecule in the cardiovascular system? Cardiovasc. Drug Rev. 25: 46-60
107. Hiley, C.R. & Kaup, S.S. (2007). Commentary: GPR55 and the vascular receptors for cannabinoids. Br. J. Pharmacol., 152:559-561.
108. Hiley, C.R. (2009). Endocannabinoids and the heart. J. Cardiovasc. Pharmacol. 53: 267-276.
109. Brown A.J. & Hiley, C.R. (2009) Chapter 5: Is GPR55 an anandamide receptor? Chapter 5: in "Anandamide, An Endogenous Cannabinoid. Vitamins and Hormones Vol. 81”" edited by G. Litwack. (Academic Press: New York). pp. 87-10